Li Lane Christensen
FDA investigator
Appears on 1 document from 2023, mostly at sites in China. Most often cites control of microbiological contamination (21 CFR 211.113).
- 1
- Documents on file
- 3.0
- Observations per 483
- 2023
- First seen
- 2023
- Most recent
What they cite most
From 3 observations- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.180General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
Activity by year
2023: 1
Where
China 1
Often inspects with
Is Li Lane Christensen coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2023-05-26 | 483 Suzhou Union Biopharm Co., Ltd.May 26, 2023 · Suzhou, China | Suzhou, China | 3 |
About this profile
What does Li Lane Christensen inspect?
Li Lane Christensen appears on 1 document on file covering 1 site, mostly in China.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.180 and 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Li Lane Christensen is dated May 26, 2023.